This website uses cookies to improve your experience. Learn more about cookies and how to manage them.
Life Sciences | 17-18 March 2019
29 Dec 2018
Patrick Vallance, Chief Scientific Officer to the UK Government and Honorary Fellow of the British Pharmacological Society, has received a knighthood for services to services to open clinical science.
19 Dec 2018
Every year, the British Pharmacological Society elects a small number of Fellows and Honorary Fellows. This year, nine Fellowships and eight Honorary Fellowships have been awarded
The first novel prophylactic medicine in nearly 20 years to treat people with haemophilia with or without Factor VIII inhibitors has been named Drug Discovery of the Year 2019.
12 Dec 2018
Professor Sir Munir Pirmohamed has been appointed by the Secretary of State as a non-executive director of NHS England.
05 Dec 2018
Taking opioids for the treatment of pain has been associated with increased risks of crashing among drivers, but it is unknown whether this applies to all opioids or pertains to specific opioids only.
13 Nov 2018
We are pleased to announce the 2018 winners of the BSc Pharmacology Prize (nominated by their university department) and the winners of the Clinical Undergraduate Prize (nominated by their medical school).
07 Nov 2018
In a British Journal of Clinical Pharmacology study of older adults prescribed statins, first-year nonadherence and discontinuation rates were high.
Statins have been linked with muscle pain and other musculoskeletal adverse events (MAEs) in some patients. A new Pharmacology Research & Perspectives study has examined the timing of MAEs that develop during statin therapy and determined whether concomitant drugs used concurrently with statin therapy shifts the timing of MAEs.
01 Nov 2018
As part of Clinical Pharmacology Month, we ran a competition for medical students in the UK. The competition celebrated the valuable work of medical students in enhancing clinical pharmacology.
17 Oct 2018
In a study of 15 patients affected by major depressive disorder and complaining of insomnia, initiating treatment with vortioxetine for their depressive symptoms led to significant improvements in subjective sleep quality and daytime sleepiness.
Contact our press office by email or on:
T. +44 (0)20 7239 0180 M. +44 (0)7786 552 498
Our normal office hours are 9am to 5pm Monday to Friday. A member of staff will try to reply to you as soon as possible.
Contact us